Healthcare Services

Cancer Stem Cells Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Cancer Stem Cells Market Between 2026 And 2030?

The cancer stem cells market has seen rapid expansion in its size over recent years. This market is projected to expand from $3.24 billion in 2025 to $3.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. Historically, this growth has been driven by factors such as advancements in stem cell biology research, the successful identification of cancer stem cell populations, an increase in oncology research funding, the expansion of preclinical cancer models, and a rise in academic-industry collaborations.

The cancer stem cells market is projected to experience swift expansion over the coming years. This market is anticipated to reach $5.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This projected growth during the forecast period is driven by several factors, including a heightened demand for long-lasting cancer treatments, increased investment in targeted oncology research, the broader adoption of personalized cancer treatment approaches, a greater emphasis on preventing metastasis, and the expanding incorporation of csc research into clinical oncology practices. Key trends expected during this period involve a heightened emphasis on developing therapies against drug-resistant cancer cells, an increase in research dedicated to csc-specific pathways, the ongoing development of csc biomarkers, an expansion of both translational and clinical csc research, and an improved integration of csc models within drug discovery processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27235&type=smp

What Major Drivers Are Influencing Demand In The Cancer Stem Cells Market?

The cancer stem cells market is projected to expand due to the increasing need for personalized medicine. Personalized medicine refers to treatment strategies designed specifically for each patient, considering their genetic makeup, tumor biology, and individual response patterns, all aimed at achieving superior effectiveness and fewer side effects. The demand for such tailored treatments is escalating because genomic sequencing technologies are becoming more accessible and affordable, and their use is widespread in oncology research and clinical care. Personalized medicine addresses cancer stem cells (CSCs) by customizing therapies based on the unique molecular and genetic characteristics of a patient’s tumor. This involves initially analyzing tumors for mutations, signaling pathways, and surface markers distinct to their CSC population, which guides clinicians in selecting treatments that inhibit critical pathways. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, announced that the Food and Drug Administration (FDA) had approved 16 new personalized treatments for rare disease patients in 2023, a rise from six in 2022. Ultimately, the growing requirement for real-time risk assessment and mitigation solutions is propelling the growth of the cancer stem cells market.

Which Market Segments Are Examined In The Cancer Stem Cells Market Study?

The cancer stem cells market covered in this report is segmented –

1) By Type: Solid Tumor Stem Cells, Hematopoietic Stem Cells, Breast Cancer Stem Cells, Colorectal Cancer Stem Cells, Brain Cancer Stem Cells, Leukemia Stem Cells

2) By Cancer Forms: Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Other Cancer Forms

3) By Mode Of Action: Targeted Cancerous Stem Cells (Cscs), Stem Cell-Based Cancer Therapy

4) By Research Type: Basic Research, Clinical Research, Preclinical Research, Translational Research

5) By End User: Pharmaceutical And Biotechnology Companies, Research And Academic Institutions, Hospitals And Laboratories, Contract Research Organizations (CROs)

Subsegments:

1) By Solid Tumor Stem Cells: Lung Cancer Stem Cells, Liver Cancer Stem Cells, Pancreatic Cancer Stem Cells, Prostate Cancer Stem Cells, Ovarian Cancer Stem Cells

2) By Hematopoietic Stem Cells: Myeloid Stem Cells, Lymphoid Stem Cells, Erythroid Stem Cells, Megakaryocytic Stem Cells, Granulocytic Stem Cells

3) By Breast Cancer Stem Cells: Triple Negative Breast Cancer Stem Cells, Hormone Receptor Positive Breast Cancer Stem Cells, Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Stem Cells, Metastatic Breast Cancer Stem Cells, Inflammatory Breast Cancer Stem Cells

4) By Colorectal Cancer Stem Cells: Adenocarcinoma Colorectal Cancer Stem Cells, Mucinous Colorectal Cancer Stem Cells, Signet Ring Cell Colorectal Cancer Stem Cells, Metastatic Colorectal Cancer Stem Cells, Serrated Colorectal Cancer Stem Cells

5) By Brain Cancer Stem Cells: Glioblastoma Stem Cells, Medulloblastoma Stem Cells, Astrocytoma Stem Cells, Oligodendroglioma Stem Cells, Ependymoma Stem Cells

6) By Leukemia Stem Cells: Acute Myeloid Leukemia Stem Cells, Chronic Myeloid Leukemia Stem Cells, Acute Lymphoblastic Leukemia Stem Cells, Chronic Lymphocytic Leukemia Stem Cells, Mixed Phenotype Acute Leukemia Stem Cells

Which Trends Are Influencing The Cancer Stem Cells Market?

Companies operating in the cancer stem cells market are increasingly focused on technological advancements, including pre-analytical immunomagnetic sorting systems, to improve cell enrichment and diagnostic accuracy. These advanced pre-analytical tools utilize magnetic particles coated with antibodies to precisely isolate specific cancer stem cell populations from complex biological samples, thereby enhancing sensitivity and reproducibility in subsequent assays. As an illustration, in March 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched its EasySep Human Bone Marrow CD138 Positive Selection Kit. This kit is noteworthy as the first hematopoietic cell enrichment product to receive FDA de novo classification as a Class II in vitro diagnostic device. It works by enriching CD138+ plasma cells from bone marrow samples to improve the detection of multiple myeloma-related abnormalities. The product ensures higher sensitivity, reproducibility, and diagnostic accuracy, ultimately leading to improved patient outcomes in multiple myeloma care. The primary objective of this product is to strengthen the pre-analytical phase of cancer diagnostics by providing high-purity cell populations, which enables more reliable downstream testing.

Who Are The Primary Competitors In The Cancer Stem Cells Market?

Major companies operating in the cancer stem cells market are MacroGenics Inc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Lonza Group AG, A. Menarini Industrie Farmaceutiche Riunite S.r.l., Bio-Techne Corporation, Zymeworks Inc., Kura Oncology Inc., GeneTex Inc., YZY Biopharma Co. Ltd., Abnova Taiwan Corporation, BioView Ltd., ScienCell Research Laboratories Inc., Boster Biological Technology Co. Ltd., AAT Bioquest Inc., Celprogen Inc., Actinium Pharmaceuticals Inc., OncoMed Pharmaceuticals Inc., Fate Therapeutics Inc., Verastem Oncology Inc.

Read the full cancer stem cells market report here:

https://www.thebusinessresearchcompany.com/report/cancer-stem-cells-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Cancer Stem Cells Market?

North America was the largest region in the cancer stem cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer stem cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cancer Stem Cells Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27235&type=smp

Browse Through More Reports Similar to the Global Cancer Stem Cells Market 2026, By The Business Research Company

Cancer Tumor Profiling Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Biomarker Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795